A Tool to Diagnose Reversible Cerebral Vasoconstriction Syndrome

A novel tool measuring a combination of clinical features can help distinguish reversible cerebral vasoconstriction syndrome from non-RCVS arteriopathies.

Because several entities can include a combination of headache and arteriographic abnormalities, differentiating among these conditions can be challenging. To develop a score to distinguish between reversible cerebral vasoconstriction syndrome (RCVS) and non-RCVS arteriopathies (e.g., moyamoya syndrome), investigators reviewed an institutional database of 110 patients, including 30 patients with RCVS and 80 patients with non-RCVS arteriopathies. The authors queried the database for demographics, cerebospinal fluid (CSF) results, and notable clinical features of RCVS such as a single or recurrent thunderclap headache (TCH) and presence of a vasoconstrictive trigger (e.g., serotonergic medications, postpartum state, sexual orgasm).

Mean age wa…

Reviewing Author

Seemant Chaturvedi, MD

Disclosures

Consultant/Advisory BoardBayer Pharmaceuticals; Novartis

Grant/Research SupportNational Institute of Neurological Disorders and Stroke

Editorial BoardsNeurology; Stroke

Seemant Chaturvedi, MD

Disclosures

Consultant/Advisory BoardBayer Pharmaceuticals; Novartis

Grant/Research SupportNational Institute of Neurological Disorders and Stroke

Editorial BoardsNeurology; Stroke

A Tool to Diagnose Reversible Cerebral Vasoconstriction Syndrome

Topics

Reviewing Author